Last reviewed · How we verify

Omega-3 supplement

Washington University School of Medicine · FDA-approved active Small molecule Under review

Omega-3 supplement is a Dietary supplement / Fatty acid Small molecule drug developed by Washington University School of Medicine. It is currently FDA-approved for Cardiovascular health and triglyceride reduction, Cognitive and neurological support, General anti-inflammatory and wellness support. Also known as: EPA Plus Minami Nutrition.

Omega-3 fatty acids reduce inflammation and support cardiovascular and neurological health by modulating lipid metabolism and inflammatory pathways.

Omega-3 supplements are polyunsaturated fatty acids found in nature, characterized by a double bond three atoms away from the terminal methyl group in their chemical structure. They have been studied in clinical trials for various conditions, including hyperlipidemia, cognitive benefits, and child development, often in comparison to placebo or other interventions such as citicoline.

At a glance

Generic nameOmega-3 supplement
Also known asEPA Plus Minami Nutrition
SponsorWashington University School of Medicine
Drug classDietary supplement / Fatty acid
ModalitySmall molecule
Therapeutic areaCardiovascular
PhaseFDA-approved

Mechanism of action

Omega-3 polyunsaturated fatty acids (EPA and DHA) are incorporated into cell membranes and serve as precursors for anti-inflammatory mediators called resolvins and protectins. They reduce triglyceride levels, improve endothelial function, and modulate immune responses through effects on inflammatory cytokines and eicosanoid production.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Omega-3 supplement

What is Omega-3 supplement?

Omega-3 supplement is a Dietary supplement / Fatty acid drug developed by Washington University School of Medicine, indicated for Cardiovascular health and triglyceride reduction, Cognitive and neurological support, General anti-inflammatory and wellness support.

How does Omega-3 supplement work?

Omega-3 fatty acids reduce inflammation and support cardiovascular and neurological health by modulating lipid metabolism and inflammatory pathways.

What is Omega-3 supplement used for?

Omega-3 supplement is indicated for Cardiovascular health and triglyceride reduction, Cognitive and neurological support, General anti-inflammatory and wellness support.

Who makes Omega-3 supplement?

Omega-3 supplement is developed and marketed by Washington University School of Medicine (see full Washington University School of Medicine pipeline at /company/washington-university-school-of-medicine).

Is Omega-3 supplement also known as anything else?

Omega-3 supplement is also known as EPA Plus Minami Nutrition.

What drug class is Omega-3 supplement in?

Omega-3 supplement belongs to the Dietary supplement / Fatty acid class. See all Dietary supplement / Fatty acid drugs at /class/dietary-supplement-fatty-acid.

What development phase is Omega-3 supplement in?

Omega-3 supplement is FDA-approved (marketed).

What are the side effects of Omega-3 supplement?

Common side effects of Omega-3 supplement include Gastrointestinal upset (nausea, diarrhea, dyspepsia), Fish aftertaste or fishy odor, Bleeding or bruising (at high doses), Headache.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing